Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification to enhance binding affinity and pharmacokinetic properties in drug candidates. Commonly employed in medicinal chemistry research to optimize lead compounds targeting specific signaling pathways involved in tumor growth and inflammation.